Thalia Therapeutics PLC Announces Acquisition and £2.75 Million Fundraise

Acquisition of oncology company Sanmirna Therapeutics Inc for its clinical-stage Acute Myeloid Leukaemia RNA therapyAcquisition catapults Thalia to a clinical-stage RNA therapeutics company and is expected to be fundamentally value accretiveAdvances …